OBJECTIVE: Medication adherence is critical to the success of antiretroviral therapies for children and youth with perinatally acquired HIV. Factors that influence successful transition of medication responsibility from caregivers to youth are poorly understood. The purpose of this study was to evaluate the relationship of medication adherence with demographic, cognitive, academic, and behavioral characteristics. METHODS: Randomly selected youth, N = 151, aged 8 to 18 years, completed cognitive and academic measures, and they and their caregivers completed questionnaires assessing behavior and emotional well-being. An announced pill count and questionnaires completed by youth and their caregivers were used to evaluate adherence. RESULTS: Of 151 participants, 100 completed all adherence measures. Adherence rates varied by assessment method. Nonadherence (<90%) by pill count was associated with older child age, greater youth responsibility for medications, and other demographic and medication regimen variables. Verbal impairment predicted better self-reported adherence and reading problems predicted better self- and caregiver-reported adherence. Youth-reported locus of control was associated with pill count nonadherence, and poor relationships with parents were associated with youth-reported nonadherence. CONCLUSIONS: Consideration of youth cognitive or academic status may be helpful in evaluating medication adherence in patients with perinatally acquired HIV infection, particularly when using self- or caregiver reports to assess adherence. Vigilance for adherence problems is indicated when youth are older, responsible for medications, report poor caregiver relationships, and/or sense a lack of control over their lives.
OBJECTIVE: Medication adherence is critical to the success of antiretroviral therapies for children and youth with perinatally acquired HIV. Factors that influence successful transition of medication responsibility from caregivers to youth are poorly understood. The purpose of this study was to evaluate the relationship of medication adherence with demographic, cognitive, academic, and behavioral characteristics. METHODS: Randomly selected youth, N = 151, aged 8 to 18 years, completed cognitive and academic measures, and they and their caregivers completed questionnaires assessing behavior and emotional well-being. An announced pill count and questionnaires completed by youth and their caregivers were used to evaluate adherence. RESULTS: Of 151 participants, 100 completed all adherence measures. Adherence rates varied by assessment method. Nonadherence (<90%) by pill count was associated with older child age, greater youth responsibility for medications, and other demographic and medication regimen variables. Verbal impairment predicted better self-reported adherence and reading problems predicted better self- and caregiver-reported adherence. Youth-reported locus of control was associated with pill count nonadherence, and poor relationships with parents were associated with youth-reported nonadherence. CONCLUSIONS: Consideration of youth cognitive or academic status may be helpful in evaluating medication adherence in patients with perinatally acquired HIV infection, particularly when using self- or caregiver reports to assess adherence. Vigilance for adherence problems is indicated when youth are older, responsible for medications, report poor caregiver relationships, and/or sense a lack of control over their lives.
Authors: Staci Martin; Deborah K Elliott-DeSorbo; Pamela L Wolters; Mary Anne Toledo-Tamula; Gregg Roby; Steve Zeichner; Lauren V Wood Journal: Pediatr Infect Dis J Date: 2007-01 Impact factor: 2.129
Authors: Russell B Van Dyke; Sophia Lee; George M Johnson; Andrew Wiznia; Kathleen Mohan; Kenneth Stanley; Edward V Morse; Paul A Krogstad; Sharon Nachman Journal: Pediatrics Date: 2002-04 Impact factor: 7.124
Authors: Charles H Hinkin; David J Hardy; Karen I Mason; Steven A Castellon; Ramani S Durvasula; Mona N Lam; Marta Stefaniak Journal: AIDS Date: 2004-01-01 Impact factor: 4.177
Authors: C H Hinkin; S A Castellon; R S Durvasula; D J Hardy; M N Lam; K I Mason; D Thrasher; M B Goetz; M Stefaniak Journal: Neurology Date: 2002-12-24 Impact factor: 9.910
Authors: Sarah L Pearlstein; Claude A Mellins; Curtis Dolezal; Katherine S Elkington; E Karina Santamaria; Cheng-Shiun Leu; Jennifer E Cruz; Elaine J Abrams Journal: J Pediatr Psychol Date: 2013-10-11
Authors: Patricia A Garvie; Sean S Brummel; Susannah M Allison; Kathleen M Malee; Claude A Mellins; Megan L Wilkins; Lynnette L Harris; E Doyle Patton; Miriam C Chernoff; Richard M Rutstein; Mary E Paul; Sharon L Nichols Journal: Pediatr Infect Dis J Date: 2017-08 Impact factor: 2.129
Authors: C Paula Lewis-de Los Angeles; Kathryn I Alpert; Paige L Williams; Kathleen Malee; Yanling Huo; John G Csernansky; Ram Yogev; Russell B Van Dyke; Elizabeth R Sowell; Lei Wang Journal: J Pediatric Infect Dis Soc Date: 2016-12 Impact factor: 3.164
Authors: Wilberforce Tumwesige; Phionah Namatovu; Ozge Sensoy Bahar; William Byansi; Mary M McKay; Fred M Ssewamala Journal: Pediatr Med Date: 2021-02-28
Authors: Olurotimi A Adejumo; Kathleen M Malee; Patrick Ryscavage; Scott J Hunter; Babafemi O Taiwo Journal: J Int AIDS Soc Date: 2015-09-16 Impact factor: 5.396